IXEMPRA
Live / Registered — Registered and renewed (as of 23 Feb 2018)
What this means for you
Registered since 18 Mar 2008. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 18 Mar 2018).
Record
- Serial number
- 78392518
- Registration number
- 3399369
- Mark type
- Stylized text
- Filed
- 29 Mar 2004
- Published for opposition
- 12 Jul 2005
- Registered
- 18 Mar 2008
- Next maintenance due
- 18 Mar 2018
- Attorney of record
- Eric A. LaMorte
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of cancer
Owner
- R-PHARM US OPERATING, LLC, Lawrenceville, NJ, US
- Bristol-Myers Squibb Company, New York, NY, US
- Bristol-Myers Squibb Company, New York, NY, US
- Bristol-Myers Squibb Company, New York, NY, US
Prosecution history
- 23 Feb 2018 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 23 Feb 2018 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 23 Feb 2018 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 31 Jan 2018 — REGISTERED - COMBINED SECTION 8 (10-YR) & SEC. 9 FILED
- 22 Feb 2018 — TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
- 21 Feb 2018 — POST REGISTRATION ACTION MAILED - SEC. 8 & 9
- 21 Feb 2018 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 31 Jan 2018 — TEAS SECTION 8 & 9 RECEIVED
- 18 Mar 2017 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 02 Sept 2015 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 04 Apr 2014 — NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
- 03 Apr 2014 — REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
- 18 Mar 2014 — REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
- 03 Apr 2014 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 18 Mar 2014 — TEAS SECTION 8 & 15 RECEIVED